메뉴 건너뛰기




Volumn 79, Issue 5, 2008, Pages 590-593

Topiramate, nutrition and weight change: A prospective study

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

EID: 42449091913     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.136929     Document Type: Article
Times cited : (32)

References (18)
  • 1
    • 0042840536 scopus 로고    scopus 로고
    • Predictors of weight loss in adults with topiramate-treated epilepsy
    • Ben-Menachem E, Axelsen M, Johanson EH, et al. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003;11:556-62.
    • (2003) Obes Res , vol.11 , pp. 556-562
    • Ben-Menachem, E.1    Axelsen, M.2    Johanson, E.H.3
  • 2
    • 0346593400 scopus 로고    scopus 로고
    • A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity
    • Bray GA, Hollander P, Klein S, et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;11:722-33.
    • (2003) Obes Res , vol.11 , pp. 722-733
    • Bray, G.A.1    Hollander, P.2    Klein, S.3
  • 3
    • 16644400954 scopus 로고    scopus 로고
    • Topiramate: Long-term maintenance of weight loss induced by a low-calorie diet in obese subjects
    • Astrup A, Caterson I, Zelissen P, et al. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 2004;12:1658-69.
    • (2004) Obes Res , vol.12 , pp. 1658-1669
    • Astrup, A.1    Caterson, I.2    Zelissen, P.3
  • 4
    • 15944367788 scopus 로고    scopus 로고
    • Meta-analysis: Pharmacologic treatment of obesity
    • Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-46.
    • (2005) Ann Intern Med , vol.142 , pp. 532-546
    • Li, Z.1    Maglione, M.2    Tu, W.3
  • 5
    • 22144479432 scopus 로고    scopus 로고
    • Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension
    • Tonstad S, Tykarski A, Weissgarten J, et al. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. Am J Cardiol 2005;96:243-51.
    • (2005) Am J Cardiol , vol.96 , pp. 243-251
    • Tonstad, S.1    Tykarski, A.2    Weissgarten, J.3
  • 6
    • 34250842579 scopus 로고    scopus 로고
    • Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: Randomized double-blind placebo-controlled trial
    • Eliasson B, Gudbjörnsdottir S, Cederholm J, et al. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. Int J Obes (Lond) 2007;31:1140-7.
    • (2007) Int J Obes (Lond) , vol.31 , pp. 1140-1147
    • Eliasson, B.1    Gudbjörnsdottir, S.2    Cederholm, J.3
  • 7
    • 33947668881 scopus 로고    scopus 로고
    • Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes
    • Stenlöf K, Rössner S, Vercruysse F, et al. Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab 2007;9:360-8.
    • (2007) Diabetes Obes Metab , vol.9 , pp. 360-368
    • Stenlöf, K.1    Rössner, S.2    Vercruysse, F.3
  • 8
    • 33846416927 scopus 로고    scopus 로고
    • The effect of topiramate on energy balance in obese men: A 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
    • Tremblay A, Chaput J, Bérubé-Parent S, et al. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol 2007;63:123-34.
    • (2007) Eur J Clin Pharmacol , vol.63 , pp. 123-134
    • Tremblay, A.1    Chaput, J.2    Bérubé-Parent, S.3
  • 9
    • 0029962314 scopus 로고    scopus 로고
    • Clinical characteristics associated with binge eating in obese females: A descriptive study
    • Mussell MP, Mitchell JE, de Zwaan M, et al. Clinical characteristics associated with binge eating in obese females: a descriptive study. Int J Obes Relat Metab Disord 1996;20:324-31.
    • (1996) Int J Obes Relat Metab Disord , vol.20 , pp. 324-331
    • Mussell, M.P.1    Mitchell, J.E.2    de Zwaan, M.3
  • 10
    • 0027417254 scopus 로고
    • Binge eating disorder: Its further validation in a multisite study
    • Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-53.
    • (1993) Int J Eat Disord , vol.13 , pp. 137-153
    • Spitzer, R.L.1    Yanovski, S.2    Wadden, T.3
  • 12
    • 0031809290 scopus 로고    scopus 로고
    • Differences in energy expenditure and substrate oxidation between habitual high fat and low fat consumers (phenotypes)
    • Cooling J, Blundell J. Differences in energy expenditure and substrate oxidation between habitual high fat and low fat consumers (phenotypes). Int J Obes Relat Metab Disord 1998;22:612-18.
    • (1998) Int J Obes Relat Metab Disord , vol.22 , pp. 612-618
    • Cooling, J.1    Blundell, J.2
  • 13
    • 20444401613 scopus 로고    scopus 로고
    • Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity
    • Schäuble N, Reichwald K, Grassl W, et al. Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity. J Nutr 2005;135:1387-92.
    • (2005) J Nutr , vol.135 , pp. 1387-1392
    • Schäuble, N.1    Reichwald, K.2    Grassl, W.3
  • 14
    • 0034128353 scopus 로고    scopus 로고
    • Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults
    • Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(Suppl 1):S66-71.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 1
    • Reife, R.1    Pledger, G.2    Wu, S.C.3
  • 15
    • 32944473060 scopus 로고    scopus 로고
    • Weight change in monozygotic twins treated with valproate
    • Klein KM, Hamer HM, Reis J, et al. Weight change in monozygotic twins treated with valproate. Obes Res 2005;13:1330-4.
    • (2005) Obes Res , vol.13 , pp. 1330-1334
    • Klein, K.M.1    Hamer, H.M.2    Reis, J.3
  • 17
    • 33645745037 scopus 로고    scopus 로고
    • Clozapine-induced weight gain: A study in monozygotic twins and same-sex sib pairs
    • Theisen FM, Gebhardt S, Haberhausen M, et al. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatr Genet 2005;15:285-9.
    • (2005) Psychiatr Genet , vol.15 , pp. 285-289
    • Theisen, F.M.1    Gebhardt, S.2    Haberhausen, M.3
  • 18
    • 14644417140 scopus 로고    scopus 로고
    • Clozapine: Weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation
    • Wehmeier PM, Gebhardt S, Schmidtke J, et al. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Psychiatry Res 2005;133:273-6.
    • (2005) Psychiatry Res , vol.133 , pp. 273-276
    • Wehmeier, P.M.1    Gebhardt, S.2    Schmidtke, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.